Long-term consequences of the misuse of ivermectin data

Alvarez-Moreno, Carlos, Cassell, Jackie A, Donkor, Claudia M, Head, Michael G, Middleton, Jo, Pomat, William, Saki, Bayaki and Yirgu, Robel (2021) Long-term consequences of the misuse of ivermectin data. Lancet Infectious Diseases. ISSN 1473-3099

[img] PDF - Accepted Version
Available under License Creative Commons Attribution-NonCommercial No Derivatives.

Download (134kB)


Ivermectin is an oral anti-infective medicine that is integral to neglected tropical disease programmes. It is safe and effective for the treatment and control of lymphatic filariasis, scabies, and onchocerciasis, sometimes as part of a mass drug administration, as recognised in the WHO road map for neglected tropical diseases 2021–30. The WHO essential medicines list provides recommendations for minimum medicine needs for a basic health-care system, which includes ivermectin as an anthelmintic, antifilarial, and antiectoparasitic treatment. There has been a groundswell of opinion across several countries that ivermectin might be useful in reducing the symptoms of and mortality due to COVID-19, with many citing meta-analyses that infer positive effects; however, these conclusions appear to be unreliable.

Item Type: Article
Additional Information: Authors listed alphabetical order of surname, all to be recognised as equal contributions
Keywords: Scabies, Global Health, Neglected Tropical Diseases, COVID-19, Evidence Based Medicine, Ivermectin, Medical acarology
Schools and Departments: Brighton and Sussex Medical School > Primary Care and Public Health
SWORD Depositor: Mx Elements Account
Depositing User: Mx Elements Account
Date Deposited: 22 Oct 2021 07:48
Last Modified: 19 Apr 2022 01:00
URI: http://sro.sussex.ac.uk/id/eprint/102416

View download statistics for this item

📧 Request an update